http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
윤혜숙(Hye Sook Yoon) 한국정보과학회 1986 정보과학회논문지 Vol.13 No.2
Unifying algorithm 및 Lock resolution strategy를 이용한 problem solver에 간단한 user interfaceㄹ르 부가하여 Language interpreter의 형식으로 PROLOG상에서 동작하는 first order logic을 이용한 간단한 Problem solver, FOLPS(First Order Logic Problem)을 구현하여 보았다. 이 논문에서는 FOLPS의 설계 및 구현에 대하여 주요 data structure 및 구현에 이용된 algorithm 등을 설명하고 문제점을 제시하고자 한다. We implemented simple problem solver, FOLPS (First Order Logic Problem Solver) which is using first order logic operating in PROLOG like language interpreter with simple user interface This problem solver adopts unifying algorithm and lock resolution strategy. This paper describes main data structure and algorithm for designing and implementing FOLPS, in addition to some problems.
천마(Gastrodia elata Blume)의 항혈소판, 항혈전활성
백영숙,송재경,윤춘희,정교순,윤혜숙,Paik, Young-Sook,Song, Jae-Kyoung,Yoon, Chun-Hee,Chung, Kyo-Soon,YunChoi, Hye-Sook 한국생약학회 1995 생약학회지 Vol.26 No.4
MeOH extract of Gastrodia elata was fractionated to five solvent fractions, hexane fr (fr I), 90% MeOH fr (fr II), EtOAc fr (fr III), BuOH fr (fr IV) and $H_2O$ fr (fr V). Among the five fractions, fr II, III and IV showed platelet anti-aggregating effects against ADP or collagen induced rat platelet aggregation in vitro. Fr II , III and IV were also tested in vivo, in the mouse and rat models of thrombosis. Oral administration of fr II, III or IV enhanced the recovery from the thrombotic shock in the mouse model of thrombosis to 32-40% from 17% of recovery with the control group of mice. Treatment with fr II, III or IV also attenuated the sudden reduction in the blood platelet count following intravenous collagen injection to rat. The above results were indicative of the presence of anti-platelet and anti-thrombotic components in this plant.
Triflusal과 Ibudilast 동시처리에 의한 혈소판응집 및 혈액응고 억제효과
황인영(In Young Hwang),손윤아(Yoon Ah Sohn),황선아(Seon A Hwang),구연경(Yean Kyoung Koo),김선영(Sun Young Kim),윤혜숙(Hye Sook Yun-Choi),권순경(Soon Kyoung Kwon),정춘식(Choon Sik Jeong) 대한약학회 2012 약학회지 Vol.56 No.4
This study aims to develop a novel regimen for enhanced efficacy and reduced side effect in inhibiting platelet aggregation and blood coagulation by concurrent administration of triflusal and ibudilast as anticoaggulants. The result shows this combination of triflusal and ibudilast (300~500 μM, respectively) has additive effect in inhibiting platelet aggregation and blood coagulation over the administration of truflusal or ibdilast as a single treatment. This pharmaceutical composition is expected to be useful for the prevention or treatment of various diseases and symptoms, for example, ischemic heart disease, ischemic cerebral infarction, arteriosclerosis, and thrombosis caused by the insertion of a stent.